Novo Nordisk’s shares fell sharply on Monday after the results from testing the Danish company’s CagriSema drug fell short of investors’ expectations.
Последние новости
，详情可参考爱思助手下载最新版本
Hinkley Point C
Nvidia’s participation in the round has been the subject of intense speculation, particularly as reports of a $100 billion investment in September gave way to reports of a smaller investment in the months that followed.